Effects of a supplement with human milk oligosaccharides on feeding in preterm infants
Official title: Feeding Tolerance and Growth of Preterm Infants Consuming a Supplement Containing Two Human Milk Oligosaccharides (HMOs): A Post-Market Study
Run by Société des Produits Nestlé (SPN) · NCT06212427 · Data updated 2026-11-12
This study tests if a special liquid supplement made from human milk can help preterm infants eat better and grow stronger.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 0 Days to 14 Days |
| Sex | All |
| Enrollment | 188 (estimated) |
| Sponsor | Société des Produits Nestlé (SPN) Industry-sponsored |
| Locations | 6 sites (Linz and 5 other locations) |
| Status | Recruiting |
| Started | November 20, 2023 |
| Main results expected | February 28, 2026 |
| Study ends | February 28, 2026 |
| Registry record updated | December 8, 2025 |
| Trial ID | NCT06212427 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are preterm infants born at or below 34 weeks gestational age and weighing less than 2500 grams.
✕Probably not a fit
Patients who are clinically unstable or have significant health issues may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the impact of a liquid supplement containing two specific human milk oligosaccharides, 2'-fucosyllactose and lacto-N-neotetraose, on feeding tolerance and growth in preterm infants. The research is conducted in a real-world setting, focusing on infants born at or below 34 weeks gestational age and weighing less than 2500 grams. The study aims to assess how well these infants tolerate feeding and monitor any adverse events associated with the supplement.
Why it matters
Potential benefit: If successful, this study could improve feeding tolerance and growth outcomes for preterm infants.
How similar studies have gone: Other studies have shown promising results with similar approaches using human milk oligosaccharides in preterm infants.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Written informed consent has been obtained from at least one parent (or other legally acceptable representative \[LAR\], if applicable) 2. Infant's parent(s)/LAR is of legal age of majority, has parental authority, must understand the consent form and other relevant study documents, and is willing and able to fulfil the requirements of the study protocol 3. Infant gestational age is ≤ 34 weeks as determined by the first day of the mother's last menstrual period or by fetal ultrasound 4. Infant birth weight ≤ 2500g 5. Infant postnatal age ≤ 14 days 6. Infant has tolerated trophic feeds (e.g., 10-15 mL/kg/day) for at least 24 hours but has not yet reached full enteral feeding Exclusion Criteria: 1. Infant is clinically unstable, for example: 1. Infant has hemodynamic instability as evidenced by clinical signs of sepsis, hypotension (MAP \< 5th percentile for age for at least three hours), or is receiving vasopressor drugs 2. Infant has received an exchange transfusion within the past 48 hours 3. Infant has had an episode of severe asphyxia at birth (PH less than 7.0) 4. Infant has signs of necrotizing enterocolitis according to modified Bell staging criteria (stage IIA or higher) 2. Major congenital (e.g., heart disease, skeletal dysplasia, chondrodystrophy, gastrointestinal obstruction or atresia) or chromosomal abnormality (e.g., trisomy 21, Turner syndrome) 3. Infant has other medical condition that, in the judgement of the investigator, would make the child inappropriate for entry into the study 4. Participation in another interventional clinical study that may interfere with the results of this study
Where it's running
-
Kepler Universitätsklinikum Linz
Linz, Austria Recruiting -
Evangelisches Waldkrankenhaus Spandau
Berlin-Spandau, Germany Recruiting -
Kinderklinik Darmstadt
Darmstadt, Germany Recruiting -
Uniklinik Heidelberg
Heidelberg, Germany Recruiting -
Klinikum Nürnberg
Nuremberg, Germany Recruiting -
Wilhelmstift Hamburg
Hamburg, Germany Withdrawn
Study contacts
- Study coordinator: Inez Sroda
- Email: Inez.Sroda@rd.nestle.com
- Phone: +41217858259
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Virtual reality–enhanced parent education for NICU caregivers
This pilot will try short VR training sessions to help parents of newborns in the NICU learn caregiving tasks and build confidence compared with standard education.
-
Parent-delivered oral stimulation to help preterm babies learn to suck
This study tests whether a 14-day program of extraoral and intraoral stimulation, taught to parents, helps preterm infants in the NICU improve sucking compared with stimulation given by a physiotherapist.
-
Analyzing proteins and peptides in human milk across different breastfeeding stages
This study looks at the proteins in breast milk at different stages of breastfeeding to see how they help newborns, especially those who are born early or are smaller in size.
-
Support for neurodevelopment in preterm infants through responsive parenting and e-health
This study tests a new online program to see if it can help parents of very preterm infants support their babies' brain development and overall growth by encouraging responsive parenting.
-
Understanding how nutrition affects growth in premature infants
This study looks at how the food that premature babies eat in the NICU affects their growth and development over three years.
-
Using cognitive behavioral therapy to help parents of premature infants in the NICU
This study is testing whether cognitive behavioral therapy can help parents of premature infants in the NICU feel less anxious and depressed, which may improve their relationship with their child and the child's development.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.